Xlife Sciences AG discloses 16.3% stake in Veraxa Biotech from business combination
Xlife Sciences AG, a Swiss corporation, disclosed beneficial ownership of 23,029,967 ordinary shares of Veraxa Biotech Holding AG, representing 16.3% of the…
16.3%23.0M